益佰制药 (600594)

Guizhou Yibai Pharmaceutical Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 79192.74
  • Circulating A-Shares(W): 79192.74
  • Earnings Per Share(RMB): -0.1100
  • Net Assets Per Share(RMB): 3.0346
  • Operating Revenue(W RMB): 144670.45
  • Total Profit(W RMB): -9301.66
  • **Net Profit Attributable to Parent(W RMB) **: -8656.26
  • Net Profit Growth Rate(%): 48.83
  • Weighted Return on Equity(%): -3.5380
  • Operating Cash Flow Per Share(RMB): 0.2570
  • Undistributed Profit Per Share(RMB): 0.8428
  • Capital Reserve Per Share(RMB): 0.8256

2. Main Business

The main business covers:

  • Drug research, development, production and sales
  • Operation and management of general hospitals, specialized cancer hospitals, cancer treatment centers and cancer physician groups

3. Company Basic Information

  • Company Name: Guizhou Yibai Pharmaceutical Co., Ltd.
  • Listing Date: 2004-03-23
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 220-1, Baiyun Avenue, Yunyan District, Guiyang City, Guizhou Province
  • Website: https://www.gzcci.com
  • Company Profile: The company was established on November 28, 2000, after being approved by Document Qian Fu Han [2000] No. 785 of Guizhou Province. It was jointly founded by nine natural persons - Ms. Dou Qiling, Mr. Ye Xiangwu, Mr. Zhu Yuexing, Mr. Yue Wei, Mr. Gan Ning, Mr. Pang Jun, Mr. Lang Hongping, Mr. Liu Hua, Mr. Jian Weiguang - and one legal entity, Harbin Xiaosheng Advertising Co., Ltd. The company was transformed into a joint stock limited company in accordance with the Company Law and relevant laws and regulations. The assets and liabilities of the former "Guizhou Yibai Pharmaceutical Co., Ltd." were inherited by the newly established "Guizhou Yibai Pharmaceutical Co., Ltd."

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangzhou Zhujiang Development Group Co., Ltd. General Legal Person 868.60 1.10

5. Concept Sectors

  • Private Hospitals
  • Medical Aesthetics Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Consecutive Losses
  • Micro & Small Cap Stocks

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information